Titan Medical Inc. Ordinary Shares
TMDI
TMDI was delisted on the 9th of March, 2023.
42 hedge funds and large institutions have $2.18M invested in Titan Medical Inc. Ordinary Shares in 2019 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 8 increasing their positions, 7 reducing their positions, and 5 closing their positions.
20% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 5
14% more repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 7
2% more funds holding
Funds holding: 41 → 42 (+1)
2.11% less ownership
Funds ownership: 8.6% → 6.49% (-2.1%)
52% less capital invested
Capital invested by funds: $4.52M → $2.18M (-$2.34M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$250K |
| 2 |
Two Sigma Advisers
New York
|
+$195K |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$157K |
| 4 |
Bank of New York Mellon
New York
|
+$102K |
| 5 |
Barclays
London,
United Kingdom
|
+$43.9K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CH
CVI Holdings
Wilmington,
Delaware
|
-$167K |
| 2 |
MCM
Masters Capital Management
Atlanta,
Georgia
|
-$162K |
| 3 |
SM
Sabby Management
Miami Beach,
Florida
|
-$149K |
| 4 |
VFA
Valeo Financial Advisors
Carmel,
Indiana
|
-$92.2K |
| 5 |
CQS
Credential Qtrade Securities
Vancouver,
|
-$58.8K |
TMDI Hedge Fund Activity: Q3 2019 in Review
42 of the 4,574 institutional investors tracked by Wall St. Rank reported a position in Titan Medical Inc. Ordinary Shares (TMDI) for Q3 2019, worth a combined $2.18M — down 52% from $4.52M a quarter earlier.
Buyers outnumbered sellers: 6 funds opened new TMDI positions and 5 closed out — a net gain of 1 holder — while 8 added to existing stakes and 7 trimmed.
The largest buyer was Morgan Stanley, adding an estimated $250K. The largest seller was CVI Holdings, exiting entirely with an estimated $167K sold.
- 42 institutional investors held Titan Medical Inc. Ordinary Shares (TMDI) as of Q3 2019, up from 41 in Q2 2019.
- Funds reported $2.18M of Titan Medical Inc. Ordinary Shares stock for Q3 2019, down 52% quarter-over-quarter.
- 6 funds opened new Titan Medical Inc. Ordinary Shares positions in Q3 2019 and 5 closed out, a net change of +1 holder.
- The largest Titan Medical Inc. Ordinary Shares buyer in Q3 2019 was Morgan Stanley, an estimated $250K added.
- The largest Titan Medical Inc. Ordinary Shares seller in Q3 2019 was CVI Holdings, an estimated $167K sold.
Based on aggregated 13F filings for Q3 2019.